- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
News 431 results
Cases & Deals
March 24, 2025
Roper Technologies, Inc. to acquire CentralReach for $1.65 billion
Press Release
March 10, 2025
Litigation and Trial Lawyer Eric White Joins King & Spalding in Chicago
In the News · Source: Law360, Bloomberg Law, Daily Report, Global Legal Chronicle, Crain's Chicago Business and Reuters The Daily Docket
March 10, 2025
Litigation and trial partner Eric White joins the firm’s Product Liability and Mass Torts practice group in Chicago
In the News · Source: Law360, Global Legal Chronicle and The AmLaw Litigation Daily
Cases & Deals
February 24, 2025
King & Spalding Secures Another Victory for Boehringer Ingelheim in Zantac-Related Retrial
Recognition
February 13, 2025
Legal 500 Deutschland 2025 Ranks King & Spalding Among Germany’s Leading Law Firms
Recognition
February 13, 2025
Chambers Global 2025 Recognizes King & Spalding as a Leading International Law Firm
In the News · Source: Law360
In the News · Source: Law360
January 29, 2025
Cory Hohnbaum and Andy Bayman represent Boehringer Ingelheim in a Zantac-related trial before an Illinois state court
In the News · Source: Report on Medicare Compliance
January 27, 2025
Kyle Gotchy discusses President Trump’s federal funding freeze and how it may impact the DEA’s recent proposed rule
In the News · Source: Law360
January 27, 2025
Liv Kiser and Michael Resch represent Beech-Nut Nutrition and Walmart before a California federal court in a dispute involving heavy metals in baby food
In the News · Source: Law360, Bloomberg Law, Reuters, POLITICO Influence, POLITICO Playbook, Thomson Reuters Westlaw Today, Attorney at Law Magazine, JDJournal, The Daily Docket and The National Law Journal
January 15, 2025
Lauren Roth, former U.S. Food and Drug Administration Associate Commissioner for Policy, joins the firm’s FDA and Life Sciences team in Washington, D.C.